Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Heterogeneity of plasma tissue factor pathway inhibitor.

Broze GJ Jr, Lange GW, Duffin KL, MacPhail L.

Blood Coagul Fibrinolysis. 1994 Aug;5(4):551-9.

PMID:
7841311
2.

Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

Wesselschmidt R, Likert K, Girard T, Wun TC, Broze GJ Jr.

Blood. 1992 Apr 15;79(8):2004-10.

3.

Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass.

Donahue BS, Gailani D, Mast AE.

J Thromb Haemost. 2006 May;4(5):1011-6.

5.

Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.

Valentin S, Nordfang O, Bregengård C, Wildgoose P.

Blood Coagul Fibrinolysis. 1993 Oct;4(5):713-20.

PMID:
8292720
7.

Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.

Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr.

J Biol Chem. 1989 Nov 5;264(31):18832-7.

10.
12.

Structure and biology of tissue factor pathway inhibitor.

Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP.

Thromb Haemost. 2001 Oct;86(4):959-72. Review.

PMID:
11686353
13.

The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.

Nordfang O, Bjørn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, Hedner U.

Biochemistry. 1991 Oct 29;30(43):10371-6.

PMID:
1931960
14.

Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae.

Petersen JG, Meyn G, Rasmussen JS, Petersen J, Bjørn SE, Jonassen I, Christiansen L, Nordfang O.

J Biol Chem. 1993 Jun 25;268(18):13344-51.

15.

The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.

Burgering MJ, Orbons LP, van der Doelen A, Mulders J, Theunissen HJ, Grootenhuis PD, Bode W, Huber R, Stubbs MT.

J Mol Biol. 1997 Jun 13;269(3):395-407.

PMID:
9199408
16.

Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparin.

Wesselschmidt R, Likert K, Huang Z, MacPhail L, Broze GJ Jr.

Blood Coagul Fibrinolysis. 1993 Oct;4(5):661-9.

PMID:
8292716
17.

Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation.

Lesnik P, Dentan C, Vonica A, Moreau M, Chapman MJ.

Arterioscler Thromb Vasc Biol. 1995 Aug;15(8):1121-30.

18.
19.
20.

Tissue factor pathway inhibitor (TFPI)--an update.

Sandset PM.

Haemostasis. 1996 Oct;26 Suppl 4:154-65. Review.

PMID:
8979119

Supplemental Content

Support Center